The naïve CFR estimator...
... is well understood to be problematic. Nick Jewell and others did some fine work on this in SARS (2003).
It can underestimate early, since deaths lag. And it can overestimate, since deaths are more easily identified than cases.
On case identification rates...
... we're kinda "passing the buck" to the adjustment factor (on which, more below).
On the lagging deaths, this would tend to make these calculations overly OPTIMISTIC, all else equal. (The pandemic is still expanding in the US of A.)
The real issue is the adjustment for inflating case numbers to total infections. I have used a factor of 10.0.
Until we get better testing and/or serology, this is really anyone's guess. To the extend that the mini-model gets it right or gets it badly wrong, a lot depends on this assumption.
The mini-model is highly sensitive to this assumption.
If factor is 5 then there are half as many true infections producing same number of deaths. The virus is worse, and final death toll is doubled.
*MUCH* depends on the adjustment factor. We need serology studies *NOW*.
This number *very* roughly corresponds to an R0 of 3.33, but that is an approximation with its own sets of assumptions. ...
... If you prefer a smaller R0 (<3.33), then, all else equal, the final herd immunity threshold is less than 70% and ostensibly the final size is smaller too.
This lowers the death toll of the mini-model.
The "mini-model" produces a crude estimate but it does not mean "the next 4 weeks". Nor, even, "the next 52 weeks".